|
TES expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.56541446472147E-14 |
| Normal-vs-Stage2 |
1.688290E-02 |
| Normal-vs-Stage3 |
6.339500E-03 |
| Normal-vs-Stage4 |
1.329830E-02 |
| Stage1-vs-Stage2 |
9.080400E-01 |
| Stage1-vs-Stage3 |
5.393700E-02 |
| Stage1-vs-Stage4 |
4.870300E-02 |
| Stage2-vs-Stage3 |
2.638000E-01 |
| Stage2-vs-Stage4 |
2.747800E-01 |
| Stage3-vs-Stage4 |
9.758400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.44089209850063E-16 |
| Normal-vs-AfricanAmerican |
7.52010000049097E-07 |
| Normal-vs-Asian |
3.594800E-01 |
| Caucasian-vs-AfricanAmerican |
9.441400E-01 |
| Caucasian-vs-Asian |
2.807000E-01 |
| AfricanAmerican-vs-Asian |
3.661200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
9.01880000014899E-07 |
| Male-vs-Female |
4.966800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.82400000000272E-05 |
| Normal-vs-Extreme_Weight |
4.04069999682122E-10 |
| Normal-vs-Obese |
8.69499999778256E-08 |
| Normal-vs-Extreme_Obese |
6.010000E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.548000E-02 |
| Normal_Weight-vs-Obese |
1.535020E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.598400E-01 |
| Extreme_Weight-vs-Obese |
8.157600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.428200E-01 |
| Obese-vs-Extreme_Obese |
2.981400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.579400E-04 |
| Normal-vs-Age(41-60Yrs) |
1.63180580159406E-12 |
| Normal-vs-Age(61-80Yrs) |
1.78029813113767E-11 |
| Normal-vs-Age(81-100Yrs) |
1.158620E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.364400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.730200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.268800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.513600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.158600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.305000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
5.604000E-02 |
| Normal-VS-KIRP CIMP |
2.369100E-04 |
| Normal-VS-Unclassified PRCC |
1.044520E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.62436730732907E-12 |
| Type1 PRCC-VS-KIRP CIMP |
7.168100E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.917400E-03 |
| Type2 PRCC-VS-KIRP CIMP |
9.805800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.016800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.721400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.240500E-04 |
| Normal-vs-N1 |
1.380580E-03 |
| Normal-vs-N2 |
1.132800E-01 |
| N0-vs-N1 |
9.266400E-01 |
| N0-vs-N2 |
6.807000E-01 |
| N1-vs-N2 |
5.754200E-01 |
|
|
